Heron Therapeutics, Inc. (HRTX) total debt

Total debt · fiscal 2025
$140.64M

Heron Therapeutics, Inc. (HRTX) carried total debt of $140.64M at the end of fiscal 2025 (December 31, 2025). That is 20.9% lower than the $177.76M of fiscal 2024. Figures as of 18 Nov 2026, 12:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$140.64M
Change on fiscal 2024
−20.9%
Highest on record
$179.63Mfiscal 2023
Lowest on record
$140.64Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Heron Therapeutics, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $179.63M in fiscal 2023 and the lowest $140.64M in fiscal 2025.

Total debt was 9.8× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Heron Therapeutics, Inc. total debt, year by year

Heron Therapeutics, Inc. (HRTX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$140.64M 20.9% down9.8×
2024$177.76M 1.0% down—
2023$179.63M 14.1% up—
2022$157.48M—11.6×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on HRTX

Heron Therapeutics, Inc., figure by figure

Heron Therapeutics, Inc. (HRTX) overview: price, valuation and scorecard

Heron Therapeutics, Inc. total debt: questions and answers

How much debt does Heron Therapeutics, Inc. have?

Heron Therapeutics, Inc. (HRTX) carried total debt of $140.64M at the end of fiscal 2025 (December 31, 2025). That is 20.9% lower than the $177.76M of fiscal 2024.

What are the highest and lowest total debt figures on record for Heron Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $179.63M in fiscal 2023 and the lowest $140.64M in fiscal 2025.

How does Heron Therapeutics, Inc.'s debt compare with its equity?

Total debt was 9.8× shareholders' equity at the end of fiscal 2025.

How is Heron Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Heron Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Heron Therapeutics, Inc. (HRTX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/HRTX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.